NCT00510991

Brief Summary

The aim of this study is to compare the efficacy of noninvasive positive pressure ventilation versus best medical therapy in patients with acute severe asthma

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at below P25 for phase_3 asthma

Timeline
Completed

Started Jul 2006

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2006

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 3, 2007

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
Last Updated

March 3, 2008

Status Verified

February 1, 2008

First QC Date

August 2, 2007

Last Update Submit

February 26, 2008

Conditions

Keywords

ASTHMA

Outcome Measures

Primary Outcomes (3)

  • Improvement in lung function defined as an increase of at least 50% in FEV1 as compared to baseline value on admission or an increase in FEV1 to > 60% of predicted value

    Time to discharge

  • Intensive care unit length of stay

    Time to discharge

  • Hospital length of stay

    Time to discharge

Secondary Outcomes (6)

  • Improvement in the clinical status

    Time to discharge

  • Disappearance of pulsus paradoxus

    Time to discharge

  • Improvement in arterial blood gases

    Time to discharge

  • Improvement in oxygen saturation

    Time to discharge

  • Requirements of FiO2 , medications.

    Time to discharge

  • +1 more secondary outcomes

Study Arms (1)

A

EXPERIMENTAL

NIPPV

Device: nippv

Interventions

nippvDEVICE
A

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • History of asthma of at least 1 year
  • FEV1 \< 50% of predicted (by age, height, and gender) or FEV1 \< 200 L/minute
  • Respiratory rate \> 30 breaths/min
  • All patients judged by the attending physician as having an acute attack of asthma ( Inability to speak in sentences in one breath, SaO2 \< 92% ,pulsus paradoxus \> 10 mm of Hg) -

You may not qualify if:

  • Smoking history of \> 10 years
  • Chronic obstructive pulmonary disease
  • Endotracheal intubation
  • Room air saturation \< 88 % or arterial PaO2 \< 55 mm of Hg
  • Hemodynamic instability defined as systolic BP \< 90 mm Hg
  • Altered state of consciousness
  • Congestive heart failure
  • Ischemic heart disease
  • Upper airway obstruction
  • Facial deformity
  • Pregnancy
  • Pulmonary infiltrates consistent with pulmonary edema or pneumonia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIMER

Chandigarh, Chandigarh, 160012, India

RECRUITING

Related Publications (1)

  • Gupta D, Nath A, Agarwal R, Behera D. A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma. Respir Care. 2010 May;55(5):536-43.

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Alok Nath, MD

    PGIMER, Chandigarh, India

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Digamber Behera, MD

CONTACT

Ritesh Agarwal, MD, DM

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 2, 2007

First Posted

August 3, 2007

Study Start

July 1, 2006

Study Completion

February 1, 2008

Last Updated

March 3, 2008

Record last verified: 2008-02

Locations